Combi-seq: A leap forward for personalized cancer therapy

Each year, around 10 million lives around the world are cut short by cancer. While the last century of research has seen the number of approved anticancer drugs grow by leaps and bounds, the sheer diversity of disease forms ...

Medical research

Study shows significant risk of sensory loss in long COVID

New research has revealed the extent of sensory loss among people suffering from long COVID, with around 30% reporting a decreased sense of smell, and a similar number finding their sense of taste continuing to be affected ...

page 1 from 40